Aptar Pharma’s site expansion in Congers, NY, was inaugurated on March 20 by Stephan Tanda, president and chief executive officer, AptarGroup; Salim Haffar, president, Aptar Pharma; and Alex Theodorakis, president, Aptar Pharma North America. The expanded state-of-the art manufacturing capabilities will be used to complete premium injectable elastomeric component manufacturing.

“The new expansion supports growth in three directions,” said Bas van Buijtenen, president, injectables division, Aptar Pharma. “It adds capacity to our network of global manufacturing sites and will be equipped with the latest technologies to meet growing quality requirements. The proximity to our North American customer base improves our service and responsiveness.”